Who is sponsoring NCT04498351?

NCT04498351 is sponsored by Cairo University.

What condition does NCT04498351 study?

NCT04498351 studies Spermatic Cord Block.

What drugs are being tested in NCT04498351?

Interventions: Control Test, Dexmedetomidine, Dexmedetomidine and magnesium sulphate, magnesium sulphate.

What is the status of NCT04498351?

NCT04498351 is currently COMPLETED.

Last reviewed 2022-04-01 · How we verify

Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine

NCT04498351 EARLY_PHASE1 COMPLETED

Using the spermatic cord block has been of great advantage, as it has been cost saving, efficient technique whether used inon its own or combination with a sedative or . Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic cord block is being a single injection technique, leading to a short postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as Dexmetedomidine (Dex), and magnesium.

Details

Lead sponsor	Cairo University
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	130
Start date	Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Oct 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Spermatic Cord Block

Interventions

Control Test
Dexmedetomidine
Dexmedetomidine and magnesium sulphate
magnesium sulphate

Countries

Egypt